United Therapeutics Corp (NASDAQ:UTHR)

104.12
Delayed Data
As of May 21
 -2.15 / -2.02%
Today’s Change
100.57
Today|||52-Week Range
152.55
-29.62%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
AssetsCash1.0B1.1B705.1M932.7M
 
 
 
 
 
Short Term Investment Cash-116.7M61.6M-362.4M227.6M
 
 
 
 
 
Cash & Short Term Investments1.1B1.2B927.4M1.3B
 
 
 
 
 
 
ReceivablesReceivables273.9M251.8M297.1M211.1M
 
 
 
 
 
 
InventoriesInventories114.1M114.4M107.9M101.5M
 
 
 
 
 
 
Current AssetsOther Current Assets60.5M62.3M115.5M64.2M
 
 
 
 
 
Current Assets1.6B1.6B1.4B1.6B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----748.2M--
 
 
Depreciation-----202.5M--
 
 
Intangible Assets45.8M45.7M45.6M45.6M
 
 
 
 
 
Other Assets79.9M79.8M209.3M91.9M
 
 
 
 
 
Total Assets2.7B2.9B2.9B3.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable126.8M143.3M8.4M203.4M
 
 
 
 
 
Short Term Debt250.0M250.0M0.000.00
 
 
 
Accrued Expenses----128.1M--
 
 
Other Current Liabilities462.0M396.1M401.7M115.0M
 
 
 
 
 
Other Liabilities838.8M789.4M444.7M318.4M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.00250.0M250.0M
 
 
 
Deferred Taxes-178.0M-177.9M-113.4M-113.4M
 
 
 
 
 
Other Liabilities47.0M47.1M50.9M50.4M
 
 
 
 
 
Total Liabilities896.2M846.9M777.5M631.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock19.2M19.2M19.2M19.2M
 
 
 
 
 
Common Equity1.8B2.1B2.1B2.4B
 
 
 
 
 
Total Shareholder Equity1.8B2.1B2.1B2.4B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding43.4M43.2M43.2M43.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.